Personal supplement reports
Class landing · Immunosuppressants

Supplements and immunosuppressants.

Transplant immunosuppressants (tacrolimus, ciclosporin, sirolimus, everolimus) have very narrow therapeutic windows. They are metabolised by CYP3A4. Any supplement that inhibits or induces CYP3A4 shifts blood levels in a way that risks either toxicity or graft rejection. This is the highest-stakes category in our database.

Hard exclusions: curcumin, quercetin, resveratrol, schisandra, berberine, bergamot, boswellia and St John’s Wort all act on CYP3A4 and are off the table on tacrolimus, ciclosporin, sirolimus and everolimus. Potassium is off the table on ciclosporin and tacrolimus too, because both make the body hold on to potassium. Immune-active supplements (echinacea, andrographis, elderberry, astragalus, cordyceps) are also avoided in transplant patients: some may push against the deliberate immunosuppression, and cordyceps, which has been studied as an add-on to it, can change how much anti-rejection medicine you need. Anything you consider should go through the transplant team first.

Database last updated 2026-11-13. Free for everyone. No account, no paywall. · Browse coverage A-Z

No affiliates. No commission. We earn nothing on what you buy.

For adults over 18. This tool gives evidence-graded information, not medical advice. Always discuss changes with your GP or pharmacist, especially if you take any medication, are pregnant, breastfeeding, or have a serious health condition.
Add every supplement you take. Type a name and click each match to add it, as many as you like.
Add all your medications, brand or generic. Type and click each match to add it.
Anything we should know? (optional)
Pick any that apply. We adjust the findings where context changes the answer.
Add all the supplements and medications you take, then check them together in one go.
Not sure where to start? Try one:

How the checker decides

Every result has a source

Each pair we have assessed is cited to a published study (PMID) or the British National Formulary, so you can read the source yourself.

Four kinds of answer

Severe, caution, no known interaction, and not yet assessed. A pair we have not assessed is never shown as clear.

  • Severe
  • Caution
  • No known interaction
  • Not yet assessed

Nothing in our data is not a clearance

When nothing in our data records a problem with a pair, the result says no known interaction at typical doses, which is not a clearance: your pharmacist or GP can check the pair against your full medical history.

Read the full methodology
The full report

A full supplement review, built around you, not a generic stack.

The free checker answers one interaction question at a time. A Distil report reviews the bigger picture: your goals, diet, medications, current supplements and any blood results you provide, then shows what appears worth keeping, changing, adding or leaving out.

  • what your diet already covers, so you are not adding a capsule for something food is already handling
  • which evidence-graded compounds are worth considering for your goals, and which were considered but left out
  • what to keep, change or stop from what you already take, plus the order to introduce anything new
  • how your medications and complete supplement stack fit together, with daily timing and a clear point for reassessment

The interaction check is one section of the full report. You also get the reasoning behind each recommendation and the evidence references used.

£49 until 30 June 2027 · £79 from 1 July 2027.

Distil's interactions database is reviewed and updated every quarter. We grade evidence transparently and publish our methodology, including every database change, at /about/methodology. This tool is information, not a substitute for clinical judgement. If you take medication and supplements together, your GP or pharmacist can review your full regimen against your medical history. If you want a full personalised stack reasoned against this same database, the Distil report is the next step up.